EMERGING TECHNOLOGY

Homeland Security Technology Consortium Announces Security Innovation Challenge, $25,000 in Prizes

ATI (Advanced Technology International) | May 21, 2022

Security Innovation Challenge
The Homeland Security Technology Consortium (HSTech), Advanced Technology International (ATI), and TechConnect announced the Security Innovation Challenge and $25,000 prize for technology solutions that represent the cutting edge in identity management.

Challenge applicants should represent privacy-centric solutions for both civilian and federal applications in the areas of: pattern recognition software, real-time analytics platforms, sensors, scanners, imaging, cybersecurity platforms, data harmonization software, and artificial intelligence (AI) and machine learning (ML).

The future security of our nation - both physical and virtual - will depend on the innovation of many kinds of people and organizations, especially private-sector non-traditional innovators, which have so much to offer on the cutting edge. The Security Innovation Challenge is the ideal route to connect your emerging security technologies with key government requirements and associated prototype funding opportunities."

Matthew Laudon, Vice President - TechConnect Division, ATI

TechConnect will invite top-ranked applicants to pitch their solutions in-person to investment, industry and military tech scouts, as well as consortium representatives at Defense TechConnect Innovation Summit, which runs from September 26-29, 2022, in Washington, D.C. Pitch presenters will compete on-site for awards from the $25,000 prize pool. Additionally, qualified applicants receive a one-year free membership in HS Tech and access to engagement opportunities through the consortium.

"The Homeland Security Technology Consortium knows that privacy-centric identity management technologies and processes remain critical capabilities to advance homeland security missions. We look forward to seeing what innovative solutions come out of this challenge to support the DHS mission," said Ari Schuler, Chairman of HSTech's Executive Committee.

Michael Dougherty, HSTech's Executive Director, remarked: "We expect this Challenge to give our Consortium members and other brilliant innovators the opportunity to assist the Department of Homeland Security in further developing capabilities to serve the national interest."

About Advanced Technology International
ATI, a public-service nonprofit based in Summerville, S.C., builds and manages collaborations that conduct research and development of new technologies to solve our nation's most pressing challenges. Fueled by a community of experts from industry, academia, and government, ATI accelerates impact by using the power of collaboration to help the federal government quickly acquire novel technologies. ATI is a subsidiary of Analytic Services, Inc. (ANSER), a public-service research institute organized as a nonprofit corporation, which is dedicated to informing decisions that shape the nation's future. 

About TechConnect
With 25+ years of experience connecting emerging technologies with unique funding and partnership opportunities, TechConnect boasts the most robust research and innovation network in the world. It employs a broad scope of tools to deliver top technologies, including open innovation programs, conferences, and open-access publications. Each year, TechConnect prospects, vets, and connects thousands of emerging technologies with corporate, investment, municipal, and national defense clients. TechConnect is a division of Advanced Technology International. 

About Homeland Security Technology Consortium
The Homeland Security Technology Consortium (HSTech) supports the collaborative R&D and rapid prototyping/piloting needs for the U.S. Department of Homeland Security and its components. HSTech sources capabilities across the homeland security and national border security technology spectrum.

Spotlight

Government and Public Sector IT leaders are currently faced with the difficult task of balancing the needs of both public servant workers and citizens.


Other News
GOVERNMENT BUSINESS

Tyler Technologies Announces 2022 Public Sector Excellence Award Winners

Tyler Technologies | May 27, 2022

Tyler Technologies, Inc. is proud to announce its 2022 Public Sector Excellence Award winners. The company selected 29 public sector clients as winners from a broad and diverse field of applicants after demonstrating their excellence in developing, deploying, or maintaining Tyler solutions within their jurisdictions in innovative ways. Tyler’s excellence awards were announced at this year’s annual Tyler Connect user conference, which was held in Indianapolis, Indiana, and attended by more than 4,100 clients. Tyler Connect offered more than 700 classes for attendees, and allowed clients to network with peers, share best practices, and learn new processes related to their Tyler solutions. We were especially excited to recognize these winners in person at Tyler Connect, our first in-person conference gathering since 2019. We are always so impressed by how these jurisdictions positively impact their communities through technology and create real change.” Lynn Moore, president and chief executive officer of Tyler These jurisdictions were recognized for their significant commitment to public service and striving for greater efficiency and effectiveness in serving their communities. More information about each winning jurisdiction can be found on our winner’s page here. Civic Services Winners City of Rancho Cordova, California Soos Creek Water & Sewer District, Washington Courts & Justice Winners Alvin Municipal Court, Texas City of Seabrook, Texas District Court of Maryland Glynn County State Court, Georgia Office of the Tribal Prosecutor, Choctaw Nation, Oklahoma Superior Court of California, County of Sonoma Data & Insights Winners Cook County Bureau of Technology, Illinois Virginia Department of Rail & Public Transportation ERP Winners City of Moreno Valley, California City of Roma, Texas City of Troy, Alabama Fauquier County Government and Public Schools, Virginia Franklin County Auditor Fiscal Division, Ohio St. Charles County, Missouri Property & Recording Winners Fort Bend Central Appraisal District, Texas (in collaboration with Williamson and Montgomery counties) Lake County, Illinois Oklahoma County Clerk’s Office, Oklahoma Public Safety Winners Calcasieu Parish Sheriff’s Office, Louisiana Calvert County Emergency Communications, Maryland Clinton Township Fire Department, Michigan Kendall County Sheriff’s Office, Illinois Roseville Police Department, California Regulatory Winner State of Connecticut Department of Administrative Services Schools Winners Dubuque Community School District, Iowa Kaneland Community Unit School District 302, Illinois Mount Airy City Schools, North Carolina Orchard Farm R-V School District, Missouri Tyler's Excellence Award submissions were evaluated by a diverse panel of Tyler leadership and judged on the following criteria: Organizational efficiency and productivity Organizational responsiveness to employees, vendors, or citizens Business value Innovation in using Tyler applications or services in unique ways Relevance to other organizations using Tyler solutions COVID-19 response in handling transitions, changes, and/or other effects from the pandemic About Tyler Technologies Tyler Technologies provides integrated software and technology services to the public sector. Tyler's end-to-end solutions empower local, state, and federal government entities to operate more efficiently and connect more transparently with their constituents and with each other. By connecting data and processes across disparate systems, Tyler's solutions are transforming how clients gain actionable insights that solve problems in their communities. Tyler has more than 37,000 successful installations across more than 12,000 locations, with clients in all 50 states, Canada, the Caribbean, Australia, and other international locations. Tyler has been recognized numerous times for growth and innovation, including Government Technology's GovTech 100 list and Forbes' "Most Innovative Growth Companies" list. More information about Tyler Technologies, an S&P 500 company headquartered in Plano, Texas.

Read More

CYBERSECURITY

Peraton Subsidiary Wins $563M DoD Cyber Crime Center (DC3) Task Order

Peraton | June 18, 2022

Perspecta Enterprise Services LLC, a Peraton subsidiary, has been awarded the Department of Defense (DoD) Cyber Crime Center (DC3) Technical, Analytical, and Business Operations Services (TABO) task order, worth up to $562.9 million over a 1-year base period and four 1-year option periods. The task order was issued by the General Services Administration (GSA) Federal Systems Integration and Management Center (FEDSIM) under the Alliant 2 Governmentwide Acquisition Contract (GWAC). Perspecta Enterprise Services will support essential DC3 missions by delivering digital forensics, multimedia forensics, technical solutions development, cyber analytics, and vulnerability sharing support for DoD and National requirements in law enforcement, counterintelligence, counterterrorism, cybersecurity, and critical infrastructure protection. DC3 is a federal cyber center, DoD center of excellence, and is the operational focal point for the Defense Industrial Base Cybersecurity Program. We are honored that DC3 has entrusted us to support its critical missions across a range of complex technical and operational domains. We look forward to providing our integrated capabilities across the cyber, defense and intelligence domains to help DC3 address an evolving and complex threat environment." Roger Mason, Ph.D., president, Space & Intelligence sector, Peraton As one of the federal government's largest full-spectrum cyber contractors, Peraton delivers robust cyber solutions and services, enabling customers to secure their digital domain, including 24x7x365 protection of the nation's most critical networks and data systems. "With computer crime being so prolific, the DoD requires experienced digital professionals now more than ever. Peraton employs some of the industry's leading digital forensic analysts and malware reverse engineers, and as a former DC3 operations leader, I am excited to bring our collective expertise to bear in service of the Center's growing responsibilities," said Bob Renko, director, Digital Forensics, Peraton. About Peraton Peraton drives missions of consequence spanning the globe and extending to the farthest reaches of the galaxy. As the world's leading mission capability integrator and transformative enterprise IT provider, we deliver trusted and highly differentiated national security solutions and technologies that keep people safe and secure. Peraton serves as a valued partner to essential government agencies across the intelligence, space, cyber, defense, citizen security, health, and state and local markets. Every day, our employees do the can't be done, solving the most daunting challenges facing our customers.

Read More

GOVERNMENT BUSINESS

Merck and Ridgeback Announce U.K. Government to Purchase Additional 1.75 Million Courses of Molnupiravir

Merck | December 22, 2021

Merck , known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the United Kingdom Government will purchase an additional 1.75 million patient courses of molnupiravir (MK-4482), an investigational oral antiviral COVID-19 medicine. In the U.K., LAGEVRIO® is the planned trademark for molnupiravir; the trademark for molnupiravir in other countries has not been approved. With this additional procurement agreement, which follows a previously announced agreement for 480,000 courses of treatment, the U.K. Government has now committed to purchase a total of 2.23 million courses of molnupiravir. In early November, molnupiravir received conditional marketing authorization in the U.K. for the treatment of mild to moderate COVID-19 in adults with a positive SARS-CoV-2 diagnostic test and who have at least one risk factor for developing severe illness. Molnupiravir is currently available in the U.K. and patients have started to receive treatment. An application for Emergency Use Authorization for molnupiravir is under review by the U.S. Food and Drug Administration. Merck has entered into advance purchase and supply agreements for molnupiravir with governments of more than 30 countries worldwide, including 21 agreements with countries in Europe. About Merck’s Global Efforts to Accelerate Access to Molnupiravir Following Regulatory Authorizations or Approvals Global access has been a priority for Merck and Ridgeback since the inception of their molnupiravir collaboration. The companies are committed to providing timely access to molnupiravir globally through our comprehensive supply and access approach, which includes investing at risk to produce millions of courses of therapy; tiered pricing based on the ability of governments to finance health care; entering into supply agreements with governments; and granting voluntary licenses to generic manufacturers and to the Medicines Patent Pool to make generic molnupiravir available in more than 100 low- and middle-income countries following local regulatory authorizations or approvals. Supply: In anticipation of the results from MOVe-OUT and the potential for regulatory authorization or approval, Merck has been producing molnupiravir at risk and expects to produce 10 million courses of treatment by the end of 2021, with at least 20 million courses to be produced in 2022. To date, Merck has shipped molnupiravir to 12 countries; in countries where it is approved or authorized, patients have begun to receive the drug. Supply agreements: Merck entered into a procurement agreement with the U.S. Government under which the company will supply approximately 3.1 million courses of molnupiravir to the U.S. Government, upon Emergency Use Authorization or approval from the U.S. Food and Drug Administration. Merck has entered into advance purchase and supply agreements for molnupiravir with governments for over 30 countries worldwide, including Australia, Canada, Korea, Japan, Thailand, United Kingdom and United States, pending regulatory authorizations, and is currently in discussions with additional governments. Merck plans to implement a tiered pricing approach based on World Bank country income criteria to reflect countries’ relative ability to finance their health response to the pandemic. Voluntary licenses: As part of its commitment to widespread global access, Merck previously announced that it has entered into a licensing agreement with the Medicines Patent Pool to increase broad access for molnupiravir in low- and middle-income countries. Additionally, Merck previously announced that the company has entered into non-exclusive voluntary licensing agreements for molnupiravir with established generic manufacturers to accelerate availability of molnupiravir in more than 100 low- and middle-income countries following approvals or emergency authorization by local regulatory agencies. Merck continues to discuss additional measures and collaborations to accelerate broad, global access to molnupiravir. About Molnupiravir Molnupiravir (MK-4482) is an investigational, orally administered form of a potent ribonucleoside analog that inhibits the replication of SARS-CoV-2, the causative agent of COVID-19. Molnupiravir has been shown to be active in several preclinical models of SARS-CoV-2, including for prophylaxis, treatment, and prevention of transmission. Pre-clinical data suggest that molnupiravir has a high barrier to the development of resistance.

Read More

GOVERNMENT FINANCE

Xlear Files Legal Response to Government’s Lawsuit

Xlear | December 23, 2021

Today, Xlear Inc. filed the company’s response to a Department of Justice lawsuit alleging violations of the Federal Trade Commission Act, among other allegations. The company denied all the Government’s allegations and leveled a series of affirmative defenses at the Government, including violations of Xlear’s First Amendment right to free speech. Nathan Jones, Xlear’s CEO, issued this statement regarding Xlear’s Response: The United States faces an already raging pandemic and yet another new, wildfire Omicron variant, which studies show is more transmissible, vaccine resistant and as severe as other strains. As a result, across the nation new cases are spiking and breaking records; hospitals are once again overflowing; schools are closing again; not only are we seeing breakthrough infections—we are facing reinfections; the NFL and the NHL have been forced to postpone games; and, there is a real risk that our lives and economy will once again have to close. It’s another COVID-Christmas in America. The nation’s vaccine-only strategy is failing. Despite this, the Federal Government continues to refuse to even discuss or consider other possible countermeasures—even though they are backed by sound science. Xlear’s Response outlines a series of studies, including two randomized clinical trials (RCTs)* and other clinical and lab data, that more than substantiate Xlear’s statements regarding COVID-19. One recent RCT study found that the use of nasal hygiene in treating COVID-19-infected people over the age of 50 reduced the risk of hospitalization 8-fold.** The Government hasn’t meaningfully challenged the legitimacy of these studies—the Government can’t, they paid for some of them and have published some of them. Nor has the Government offered conflicting studies—they can’t. The Government has known about these other countermeasures since June 2020. Yet, the Government still refuses to even discuss or consider them. The Response we filed also includes a new in vitro study done at Utah State University’s Institute for Antiviral Research.*** This new in vitro study (using human airway tissue) found that the components in Xlear were significantly more effective antivirals against the Delta strain of COVID-19 than Remdesivir, the Government-approved antiviral medicine. Ironically, the Government alleges it is Xlear that has misled the public. Not only is the Government refusing to consider other countermeasures, the Government, through this lawsuit, has sought to censor us from informing the American people about the science. The American people have both the right and the need to know the science. We hope this lawsuit serves as a vehicle to inform the public, as well as expose the abject failures of our Government in responding to this pandemic.

Read More